2002
DOI: 10.1016/s0006-291x(02)00637-x
|View full text |Cite
|
Sign up to set email alerts
|

Identification of autoantibodies associated with systemic lupus erythematosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
44
0
7

Year Published

2004
2004
2016
2016

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 56 publications
(51 citation statements)
references
References 33 publications
0
44
0
7
Order By: Relevance
“…We have previously shown that anti-Gal-8 autoantibodies produced by SLE patients block the interaction of Gal-8 with β1 integrins involved in its apoptotic action upon activated T cells (Norambuena et al, 2009). Autoantibodies against diff erent members of the galectin family such as Gal-1, -2, -3, and -4 been detected in patients with diff erent types of autoimmune diseases and in cancer (Lutomski et al, 1997;Giordanengo et al, 2001;Jensen-Jarolim et al, 2001;Lim et al, 2002;Romero et al, 2006;Montiel et al, 2010). However, whether autoantibodies against galectins interfere with galectin function in the immune system and whether they play pathogenic roles are poorly studied.…”
Section: Discussionmentioning
confidence: 99%
“…We have previously shown that anti-Gal-8 autoantibodies produced by SLE patients block the interaction of Gal-8 with β1 integrins involved in its apoptotic action upon activated T cells (Norambuena et al, 2009). Autoantibodies against diff erent members of the galectin family such as Gal-1, -2, -3, and -4 been detected in patients with diff erent types of autoimmune diseases and in cancer (Lutomski et al, 1997;Giordanengo et al, 2001;Jensen-Jarolim et al, 2001;Lim et al, 2002;Romero et al, 2006;Montiel et al, 2010). However, whether autoantibodies against galectins interfere with galectin function in the immune system and whether they play pathogenic roles are poorly studied.…”
Section: Discussionmentioning
confidence: 99%
“…72 In particular, autoantibodies to the catalytic fragment of PARP-1 were found in the sera of nearly 50% patients with SLE whereas they were not present in the sera of patients with rheumatoid arthritis, systemic sclerosis or healthy donors. 73,74 It is noted that in the standard 'supershift' experiment in Figure 4d, all three antibodies caused a neutralizing effect rather than a 'supershifting' one. This suggests that the antibodies likely interfered directly with the binding of PARP-1 to DNA by, for example, recognizing epitopes located within the region of the protein that interact with DNA.…”
Section: Parp-1 Regulates Il-10 Snp-mediated Transcription Ey Chung Ementioning
confidence: 92%
“…This analysis can also be applied to patients with autoimmune disease (20), such as Sjögren's syndrome (34), systemic lupus erythematosus (24), and giant cell arteritis and polymyalgia rheumatica (40).…”
Section: Discussionmentioning
confidence: 99%